Clinical Trials: Heart

Search all clinical trials | Browse by research topic
2 results

This is a Phase 4, randomized clinical trial to evaluate whether addition of Vorapaxar 2.08 mg daily vs. placebo daily on background antiplatelet therapy, prescribed for 6 months to patients with established peripheral artery disease (PAD) and Intermittent Claudication (IC) treated with standard medical therapy (SMT) would lead to an improvement in the peak walking time (PWT).

Multiple Locations

This is a prospective, multicenter randomized trial. The purpose of this study is to evaluate the effectiveness and safety of hybrid coronary revascularization (HCR) compared to multi-vessel percutaneous cardiac intervention (PCI) with metallic drug-eluting stents (DES) in patients with multi-vessel coronary artery diseease (CAD) involving the Left Anterior Descending (LAD) and Left Main (LM) arteries.

Multiple Locations

Make an appointment

(888) 321-DOCS